{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:04:18Z","timestamp":1781139858220,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04940-2","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:53:41Z","timestamp":1777334021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global trends in early-onset liver cancer incidence and projections to 2050 based on the global burden of disease study 2021"],"prefix":"10.1007","volume":"17","author":[{"given":"Zhihong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"4940_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4940_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, et al. Liver diseases: epidemiology, causes, trends and predictions. Sig Transduct Target Ther. 2025;10:33. https:\/\/doi.org\/10.1038\/s41392-024-02072-z.","journal-title":"Sig Transduct Target Ther"},{"key":"4940_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20:864\u201384. https:\/\/doi.org\/10.1038\/s41571-023-00825-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"4940_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee H-Y, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656\u201373. https:\/\/doi.org\/10.1038\/s41571-022-00672-8.","journal-title":"Nat Rev Clin Oncol"},{"key":"4940_CR5","doi-asserted-by":"publisher","first-page":"19544","DOI":"10.1038\/s41598-024-70526-z","volume":"14","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, Suparan K, Sukphutanan B, Kaeosri C, Tothanarungroj P, Sirimangklanurak S, et al. Changes in the epidemiological trends of primary liver cancer in the Asia\u2013Pacific region. Sci Rep. 2024;14:19544. https:\/\/doi.org\/10.1038\/s41598-024-70526-z.","journal-title":"Sci Rep"},{"key":"4940_CR6","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1007\/s10620-024-08549-9","volume":"69","author":"Y Guan","year":"2024","unstructured":"Guan Y, Gan Y, An J. Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data. Dig Dis Sci. 2024;69:3563\u201373. https:\/\/doi.org\/10.1007\/s10620-024-08549-9.","journal-title":"Dig Dis Sci"},{"key":"4940_CR7","doi-asserted-by":"publisher","first-page":"e28497","DOI":"10.1016\/j.heliyon.2024.e28497","volume":"10","author":"H Zhu","year":"2024","unstructured":"Zhu H, Zhao S, Zhao T, Chen L, Li S, Ji K, et al. Comparison of metastasis and prognosis between early-onset and late-onset hepatocellular carcinoma: A population-based study. Heliyon. 2024;10:e28497. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28497.","journal-title":"Heliyon"},{"key":"4940_CR8","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1245\/s10434-025-17042-0","volume":"32","author":"DS Cheah","year":"2025","unstructured":"Cheah DS, Tsai K, Kawano F, Kemprecos HJ, Salirrosas O, Tigranyan A, et al. Are More Young, Western Patients Also Developing Hepatocellular Carcinoma? Ann Surg Oncol. 2025;32:3924\u201332. https:\/\/doi.org\/10.1245\/s10434-025-17042-0.","journal-title":"Ann Surg Oncol"},{"key":"4940_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2555518","volume":"57","author":"Y-Q Gong","year":"2025","unstructured":"Gong Y-Q, Lu C-J, Xiao Y-R, Zhang J-Y, Xu Z, Li J, et al. Epidemiological trends of early-onset gastrointestinal cancers from 1990 to 2021 and predictions for 2036: analysis from the Global Burden of Disease Study 2021. Ann Med. 2025;57:2555518. https:\/\/doi.org\/10.1080\/07853890.2025.2555518.","journal-title":"Ann Med"},{"key":"4940_CR10","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04167","volume":"13","author":"C Guo","year":"2023","unstructured":"Guo C, Liu Z, Lin C, Fan H, Zhang X, Wang H, et al. Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors from 2010 to 2019. J Glob Health. 2023;13:04167. https:\/\/doi.org\/10.7189\/jogh.13.04167.","journal-title":"J Glob Health"},{"key":"4940_CR11","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"M Brauer","year":"2024","unstructured":"Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2162\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4.","journal-title":"Lancet"},{"key":"4940_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2:e000049. https:\/\/doi.org\/10.1136\/bmjonc-2023-000049.","journal-title":"BMJ Oncol"},{"key":"4940_CR13","doi-asserted-by":"publisher","first-page":"23416","DOI":"10.18632\/aging.203620","volume":"13","author":"RIR Macias","year":"2021","unstructured":"Macias RIR, Monte MJ, Serrano MA, Gonz\u00e1lez-Santiago JM, Mart\u00edn-Arribas I, Sim\u00e3o AL, et al. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging. 2021;13:23416\u201334. https:\/\/doi.org\/10.18632\/aging.203620.","journal-title":"Aging"},{"key":"4940_CR14","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/jnci\/92.24.2023","volume":"92","author":"MW Yu","year":"2000","unstructured":"Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:2023\u20138. https:\/\/doi.org\/10.1093\/jnci\/92.24.2023.","journal-title":"J Natl Cancer Inst"},{"key":"4940_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biology12070984","volume":"12","author":"R Nevola","year":"2023","unstructured":"Nevola R, Tortorella G, Rosato V, Rinaldi L, Imbriani S, Perillo P, et al. Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma. Biology. 2023;12:984. https:\/\/doi.org\/10.3390\/biology12070984.","journal-title":"Biology"},{"key":"4940_CR16","first-page":"868","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","unstructured":"Centers for Disease Control and Prevention (CDC). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:868\u201370.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4940_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.15585\/mmwr.mm6808a2","volume":"68","author":"J Woodring","year":"2019","unstructured":"Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme RA. Progress toward Hepatitis B control and elimination of mother-to-child transmission of Hepatitis B Virus - Western Pacific Region, 2005\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68:195\u2013200. https:\/\/doi.org\/10.15585\/mmwr.mm6808a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4940_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","volume":"82","author":"EY Tan","year":"2025","unstructured":"Tan EY, Danpanichkul P, Yong JN, Yu Z, Tan DJH, Lim WH, et al. Liver cancer in 2021: Global Burden of Disease study. J Hepatol. 2025;82:851\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2024.10.031.","journal-title":"J Hepatol"},{"key":"4940_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28171","volume":"6","author":"B Koh","year":"2023","unstructured":"Koh B, Tan DJH, Ng CH, Fu CE, Lim WH, Zeng RW, et al. Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019. JAMA Netw Open. 2023;6:e2328171. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.28171.","journal-title":"JAMA Netw Open"},{"key":"4940_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071133","volume":"17","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, Pang Y, Auttapracha T, Al Ta\u2019ani O, Suenghataiphorn T, Kaewdech A, et al. Rising incidence of early-onset liver cancer and intrahepatic bile duct cancer: analysis of the National Childhood Cancer Registry Database. Cancers (Basel). 2025;17:1133. https:\/\/doi.org\/10.3390\/cancers17071133.","journal-title":"Cancers (Basel)"},{"key":"4940_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10552-024-01955-4","volume":"36","author":"M-C Hsieh","year":"2025","unstructured":"Hsieh M-C, Ratnapradipa KL, Rozek L, Wen S, Chiu Y-W, Peters ES. Temporal trends and patterns for early- and late-onset adult liver cancer incidence vary by race\/ethnicity, subsite, and histologic type in the United States from 2000 to 2019. Cancer Causes Control. 2025;36:551\u201360. https:\/\/doi.org\/10.1007\/s10552-024-01955-4.","journal-title":"Cancer Causes Control"},{"key":"4940_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003928","author":"Y Li","year":"2025","unstructured":"Li Y, Guo C, Wang H, Zhang X, Zhao S, Hu J, et al. Age-specific patterns and trends of primary liver cancer: a worldwide incidence analysis. Int J Surg. 2025(2). https:\/\/doi.org\/10.1097\/JS9.0000000000003928.","journal-title":"Int J Surg"},{"key":"4940_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.32758","volume":"77","author":"DJH Tan","year":"2023","unstructured":"Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX, et al. Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH. Hepatology. 2023;77:1150\u201363. https:\/\/doi.org\/10.1002\/hep.32758.","journal-title":"Hepatology"},{"key":"4940_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01530-2","volume":"406","author":"The Lancet","year":"2025","unstructured":"The Lancet. Reversing the rise of liver cancer. Lancet. 2025;406:665. https:\/\/doi.org\/10.1016\/S0140-6736(25)01530-2.","journal-title":"Lancet"},{"key":"4940_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251363687","volume":"32","author":"B Ma","year":"2025","unstructured":"Ma B, Zheng K, Lee F-C, Lu Y. Racial disparities in comorbidity patterns of early-onset liver cancer: a machine learning analysis. Cancer Control. 2025;32:10732748251363687. https:\/\/doi.org\/10.1177\/10732748251363687.","journal-title":"Cancer Control"},{"key":"4940_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun H-C, Xu Y, Zeng H, El-Serag HB, Lee JM, et al. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet. 2025;406:731\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(25)01042-6.","journal-title":"Lancet"},{"key":"4940_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/CEJ.0000000000000428","volume":"27","author":"A Baecker","year":"2018","unstructured":"Baecker A, Liu X, La Vecchia C, Zhang Z-F. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27:205\u201312. https:\/\/doi.org\/10.1097\/CEJ.0000000000000428.","journal-title":"Eur J Cancer Prev"},{"key":"4940_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.cgh.2024.02.011","volume":"22","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, Ng CH, Tan DJH, Wijarnpreecha K, Huang DQ, Noureddin M, et al. The global burden of alcohol-associated cirrhosis and cancer in young and middle-aged adults. Clinical Gastroenterology and Hepatology. 2024;22:1947-1949.e3. https:\/\/doi.org\/10.1016\/j.cgh.2024.02.011.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"4940_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/17474124.2021.1877136","volume":"15","author":"R Nevola","year":"2021","unstructured":"Nevola R, Rinaldi L, Zeni L, Romano C, Marrone A, Galiero R, et al. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Review of Gastroenterology & Hepatology. 2021;15:643\u201356. https:\/\/doi.org\/10.1080\/17474124.2021.1877136.","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"4940_CR30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/cam4.4551","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on Global Burden of Disease Study 2019. Cancer Medicine. 2022;11:1310\u201323. https:\/\/doi.org\/10.1002\/cam4.4551.","journal-title":"Cancer Medicine"},{"key":"4940_CR31","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2024.0149","author":"M Cao","year":"2024","unstructured":"Cao M, Xia C, Cao M, Yang F, Yan X, He S, et al. Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends. Cancer Biol Med. 2024. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0149.","journal-title":"Cancer Biol Med"},{"key":"4940_CR32","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.14309\/ajg.0000000000003288","volume":"120","author":"C Wu","year":"2025","unstructured":"Wu C, Targher G, Byrne CD, Mao Y, Cheung TT, Yilmaz Y, et al. Global, regional, and national burden of primary liver cancer attributable to metabolic risks: An analysis of the Global Burden of Disease Study 1990\u20132021. Am J Gastroenterol. 2025;120:2280\u201390. https:\/\/doi.org\/10.14309\/ajg.0000000000003288.","journal-title":"Am J Gastroenterol"},{"key":"4940_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040609","volume":"17","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, Pang Y, Diaz LA, Arab JP, Hwang SY, Dejvajara D, et al. Young adults and alcohol-associated liver cancer: Incidence and death from 2000 to 2021. Cancers. 2025;17:609. https:\/\/doi.org\/10.3390\/cancers17040609.","journal-title":"Cancers"},{"key":"4940_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jncc.2024.05.002","volume":"4","author":"L Li","year":"2024","unstructured":"Li L, Shan T, Zhang D, Ma F. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study. Journal of the National Cancer Center. 2024;4:223\u201332. https:\/\/doi.org\/10.1016\/j.jncc.2024.05.002.","journal-title":"Journal of the National Cancer Center"},{"key":"4940_CR35","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/jnci\/djae163","volume":"116","author":"W Chen","year":"2024","unstructured":"Chen W, Altshuler RD, Daschner P, Salvador Morales C, St. Germain DC, Guida J, et al. Older adults with cancer and common comorbidities\u2014challenges and opportunities in improving their cancer treatment outcomes. JNCI: Journal of the National Cancer Institute. 2024;116:1730\u20138. https:\/\/doi.org\/10.1093\/jnci\/djae163.","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"4940_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-21784-7","volume":"25","author":"MT Islam","year":"2025","unstructured":"Islam MT, Saif MSI, Alam N, Pepper S, Ratnayake I, Mudaranthakam DP. Evaluating the risk of comorbidity onset in elderly patients after a cancer diagnosis. BMC Public Health. 2025;25:640. https:\/\/doi.org\/10.1186\/s12889-025-21784-7.","journal-title":"BMC Public Health"},{"key":"4940_CR37","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.950","author":"P Ndom","year":"2019","unstructured":"Ndom P. Cancer prevention in Africa: liver cancer. ecancer J. 2019. https:\/\/doi.org\/10.3332\/ecancer.2019.950.","journal-title":"ecancer J"},{"key":"4940_CR38","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/CM9.0000000000003264","volume":"137","author":"Q Li","year":"2024","unstructured":"Li Q, Ding C, Cao M, Yang F, Yan X, He S, et al. Global epidemiology of liver cancer 2022: an emphasis on geographic disparities. Chin Med J. 2024;137:2334\u201342. https:\/\/doi.org\/10.1097\/CM9.0000000000003264.","journal-title":"Chin Med J"},{"issue":"1","key":"4940_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12889-025-22026-6","volume":"25","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Zeng G, Dai H, Bian Y, Wang L, Cao W, et al. Global, regional and national burden of liver cancer 1990\u20132021: a systematic analysis of the global burden of disease study 2021. BMC Public Health. 2025;25:931. https:\/\/doi.org\/10.1186\/s12889-025-22026-6.","journal-title":"BMC Public Health"},{"key":"4940_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1609816","volume":"12","author":"J Tang","year":"2025","unstructured":"Tang J, Zheng N, Yan Y-X, Zhang N, Ren X-M. 1990\u20132021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease. Front Med. 2025;12:1609816. https:\/\/doi.org\/10.3389\/fmed.2025.1609816.","journal-title":"Front Med"},{"key":"4940_CR41","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","volume":"23","author":"S Singh","year":"2017","unstructured":"Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: a review. World J Gastroenterol. 2017;23:6549\u201370. https:\/\/doi.org\/10.3748\/wjg.v23.i36.6549.","journal-title":"World J Gastroenterol"},{"key":"4940_CR42","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388:e19-23. https:\/\/doi.org\/10.1016\/S0140-6736(16)30388-9.","journal-title":"Lancet"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04940-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04940-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04940-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:50:56Z","timestamp":1781139056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04940-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4940"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04940-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a secondary analysis of publicly available, de-identified, and aggregated data from the Global Burden of Disease Study 2021 (GBD 2021). No ethical approval or informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"889"}}